Du Manoir S - Search Results

1

Circulating DNA as a Strong Multimarker Prognostic Tool for Metastatic Colorectal Cancer Patient Management Care.

El Messaoudi S, Mouliere F, Du Manoir S, Bascoul-Mollevi C, Gillet B, Nouaille M, Fiess C, Crapez E, Bibeau F, Theillet C, Mazard T, Pezet D, Mathonnet M, Ychou M, Thierry AR. El Messaoudi S, et al. Among authors: du manoir s. Clin Cancer Res. 2016 Jun 15;22(12):3067-77. doi: 10.1158/1078-0432.CCR-15-0297. Epub 2016 Feb 4. Clin Cancer Res. 2016. PMID: 26847055

2

Therapeutic Activity of Anti-AXL Antibody against Triple-Negative Breast Cancer Patient-Derived Xenografts and Metastasis.

Leconet W, Chentouf M, du Manoir S, Chevalier C, Sirvent A, Aït-Arsa I, Busson M, Jarlier M, Radosevic-Robin N, Theillet C, Chalbos D, Pasquet JM, Pèlegrin A, Larbouret C, Robert B. Leconet W, et al. Among authors: du manoir s. Clin Cancer Res. 2017 Jun 1;23(11):2806-2816. doi: 10.1158/1078-0432.CCR-16-1316. Epub 2016 Dec 6. Clin Cancer Res. 2017. PMID: 27923843

3

Machine Learning-Assisted Evaluation of Circulating DNA Quantitative Analysis for Cancer Screening.

Tanos R, Tosato G, Otandault A, Al Amir Dache Z, Pique Lasorsa L, Tousch G, El Messaoudi S, Meddeb R, Diab Assaf M, Ychou M, Du Manoir S, Pezet D, Gagnière J, Colombo PE, Jacot W, Assénat E, Dupuy M, Adenis A, Mazard T, Mollevi C, Sayagués JM, Colinge J, Thierry AR. Tanos R, et al. Among authors: du manoir s. Adv Sci (Weinh). 2020 Jul 29;7(18):2000486. doi: 10.1002/advs.202000486. eCollection 2020 Sep. Adv Sci (Weinh). 2020. PMID: 32999827 Free PMC article.

4

Ovarian carcinoma patient derived xenografts reproduce their tumor of origin and preserve an oligoclonal structure.

Colombo PE, du Manoir S, Orsett B, Bras-Gonçalves R, Lambros MB, MacKay A, Nguyen TT, Boissière F, Pourquier D, Bibeau F, Reis-Filho JS, Theillet C. Colombo PE, et al. Among authors: du manoir s. Oncotarget. 2015 Sep 29;6(29):28327-40. doi: 10.18632/oncotarget.5069. Oncotarget. 2015. PMID: 26334103 Free PMC article.

5

Distinct oncogenes drive different genome and epigenome alterations in human mammary epithelial cells.

Fonti C, Saumet A, Abi-Khalil A, Orsetti B, Cleroux E, Bender A, Dumas M, Schmitt E, Colinge J, Jacot W, Weber M, Sardet C, du Manoir S, Theillet C. Fonti C, et al. Among authors: du manoir s. Int J Cancer. 2019 Sep 1;145(5):1299-1311. doi: 10.1002/ijc.32413. Epub 2019 Jun 10. Int J Cancer. 2019. PMID: 31093963 Free article.

6

Genomic and expression profiling of chromosome 17 in breast cancer reveals complex patterns of alterations and novel candidate genes.

Orsetti B, Nugoli M, Cervera N, Lasorsa L, Chuchana P, Ursule L, Nguyen C, Redon R, du Manoir S, Rodriguez C, Theillet C. Orsetti B, et al. Among authors: du manoir s. Cancer Res. 2004 Sep 15;64(18):6453-60. doi: 10.1158/0008-5472.CAN-04-0756. Cancer Res. 2004. PMID: 15374954 Free article.

7

Breast tumor PDXs are genetically plastic and correspond to a subset of aggressive cancers prone to relapse.

du Manoir S, Orsetti B, Bras-Gonçalves R, Nguyen TT, Lasorsa L, Boissière F, Massemin B, Colombo PE, Bibeau F, Jacot W, Theillet C. du Manoir S, et al. Mol Oncol. 2014 Mar;8(2):431-43. doi: 10.1016/j.molonc.2013.11.010. Epub 2013 Dec 19. Mol Oncol. 2014. PMID: 24394560 Free PMC article. Clinical Trial.

8

Slug/Pcad pathway controls epithelial cell dynamics in mammary gland and breast carcinoma.

Idoux-Gillet Y, Nassour M, Lakis E, Bonini F, Theillet C, Du Manoir S, Savagner P. Idoux-Gillet Y, et al. Among authors: du manoir s. Oncogene. 2018 Feb 1;37(5):578-588. doi: 10.1038/onc.2017.355. Epub 2017 Oct 9. Oncogene. 2018. PMID: 28991231

9

In high-grade ovarian carcinoma, platinum-sensitive tumor recurrence and acquired-resistance derive from quiescent residual cancer cells that overexpress CRYAB, CEACAM6, and SOX2.

du Manoir S, Delpech H, Orsetti B, Jacot W, Pirot N, Noel J, Colombo PE, Sardet C, Theillet C. du Manoir S, et al. J Pathol. 2022 Jul;257(3):367-378. doi: 10.1002/path.5896. Epub 2022 Apr 20. J Pathol. 2022. PMID: 35302657 Free article.

10

Multi-Level Control of the ATM/ATR-CHK1 Axis by the Transcription Factor E4F1 in Triple-Negative Breast Cancer.

Batnini K, Houles T, Kirsh O, Du Manoir S, Zaroual M, Delpech H, Fallet C, Lacroix M, Le Cam L, Theillet C, Sardet C, Rodier G. Batnini K, et al. Among authors: du manoir s. Int J Mol Sci. 2022 Aug 16;23(16):9217. doi: 10.3390/ijms23169217. Int J Mol Sci. 2022. PMID: 36012478 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

76 results

Search Page